Table 2.
Enrolled populations’ medical devices and underlying health impairment.
| Variable | Enrolled population (N=1947) |
|---|---|
| At least one medical device (any type), n (%) | 382 (19%) |
| Urinary catheter, n (%) | 213 (11%) |
| Endovascular catheter (peripheral or central), n (%) | 131 (7%) |
| PEG, n (%) | 91 (5%) |
| Tracheostomy, n (%) | 26 (1%) |
| Nasogastric tube, n (%) | 9 (0.4%) |
| Others (urostomy, colostomy), n (%) | 22 (1%) |
| Abdominal drainage, n (%) | 0 (0%) |
| At least one disease, n (%) | 1510 (77%) |
| Diabetes, n (%) | 433 (22%) |
| COPD, n (%) | 226 (11%) |
| Active cancer, n (%) | 180 (9%) |
| Cirrhosis, n (%) | 115 (6%) |
| IBD, n (%) | 62 (3%) |
| Immunodeficiency *, n (%) | 66 (3%) |
| End stage renal disease, n (%) | 19 (1%) |
PEG, percutaneous endoscopic gastrostomy; COPD, chronic obstructive pulmonary disease; IBD, inflammatory bowel disease; * both HIV chronic infection, cancer chemotherapy and steroid or other immunosuppressant treatment.